Joseph Renzulli, MD, FACS
Associate Professor of Urology; Chief of Urology at Lawrence + Memorial Hospital, Urology; Chief of Urology at Westerly Hospital, Urology
Research & Publications
Biography
News
Coauthors
Selected Publications
- MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACTShore N, Renzulli J, Fleshner N, Hollowell C, Vourganti S, Silberstein J, Siddiqui R, Hairston J, Elsouda D, Russell D, Cooperberg M, Tomlins S. MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT. Journal Of Urology 2021, 206: e1099-e1099. DOI: 10.1097/ju.0000000000002102.17.
- A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC).Ross A, Armstrong A, Pieczonka C, Bailen J, Tutrone R, Cooperberg M, Pavlovich C, Renzulli J, Haynes H, Sheikh N, Shore N. A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2020, 38: 321-321. DOI: 10.1200/jco.2020.38.6_suppl.321.
- PD52-03 THE ASSOCIATION OF EDUCATION LEVEL WITH THE UTILIZATION OF SHARED DECISION MAKING IN PROSTATE CANCER SCREENINGPereira J, Gershman B, Renzulli J. PD52-03 THE ASSOCIATION OF EDUCATION LEVEL WITH THE UTILIZATION OF SHARED DECISION MAKING IN PROSTATE CANCER SCREENING. Journal Of Urology 2018, 199: e981-e982. DOI: 10.1016/j.juro.2018.02.2355.
- MP92-19 NOVEL, NONTOXIC SKIN CARE FORMULATION ASSOCIATED WITH LOWER CAUTI RATES FOR HIGH-RISK ICU, NEURO, C-V AND TRAUMA PATIENTS WHEN USED FOR FOLEY CATHETER INSERTION AND MAINTENANCETurini G, Renzulli J. MP92-19 NOVEL, NONTOXIC SKIN CARE FORMULATION ASSOCIATED WITH LOWER CAUTI RATES FOR HIGH-RISK ICU, NEURO, C-V AND TRAUMA PATIENTS WHEN USED FOR FOLEY CATHETER INSERTION AND MAINTENANCE. Journal Of Urology 2017, 197: e1235. DOI: 10.1016/j.juro.2017.02.2880.
- MP97-13 ASSOCIATION OF EXTENDED PELVIC LYMPH NODE DISSECTION WITH THROMBOEMBOLIC EVENTS AND LYMPHOCELE FORMATION AMONG MEN UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTIONPereira J, Shillan H, Tucci C, Pareek G, Golijanin D, Gershman B, Renzulli J. MP97-13 ASSOCIATION OF EXTENDED PELVIC LYMPH NODE DISSECTION WITH THROMBOEMBOLIC EVENTS AND LYMPHOCELE FORMATION AMONG MEN UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTION. Journal Of Urology 2017, 197: e1308. DOI: 10.1016/j.juro.2017.02.3057.
- MP14-05 THE ASSOCIATION OF AGE WITH PERIOPERATIVE MORBIDITY AND MORTALITY AMONG PATIENTS UNDERGOING RADICAL PROSTATECTOMYPereira J, Pareek G, Golijanin D, Renzulli J, Gershman B. MP14-05 THE ASSOCIATION OF AGE WITH PERIOPERATIVE MORBIDITY AND MORTALITY AMONG PATIENTS UNDERGOING RADICAL PROSTATECTOMY. Journal Of Urology 2017, 197: e163-e164. DOI: 10.1016/j.juro.2017.02.469.
- 781 Perioperative morbidity of open versus minimally invasive partial nephrectomy: A contemporary analysis of the National Surgical Quality Improvement Program (NSQIP)Pereira J, Renzulli J, Pareek G, Moreira D, Golijanin D, Gershman B. 781 Perioperative morbidity of open versus minimally invasive partial nephrectomy: A contemporary analysis of the National Surgical Quality Improvement Program (NSQIP). European Urology Open Science 2017, 16: e1352-e1353. DOI: 10.1016/s1569-9056(17)30834-5.
- The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical ProstatectomyTurini G, Clark M, Machan J, Tucci C, Renzulli J. The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical Prostatectomy. Urology Practice 2016, 4: 232-238. PMID: 37592643, DOI: 10.1016/j.urpr.2016.06.006.
- Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease.Leone A, Diorio G, Brito J, Zargar K, Pareek G, Renzulli J, Dickinson S, Amin A, Sexton W, Spiess P, Poch M, Golijanin D. Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease. Journal Of Clinical Oncology 2016, 34: e16126-e16126. DOI: 10.1200/jco.2016.34.15_suppl.e16126.
- PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION?Rotker K, Brito J, Edmund L, Matoso A, Renzulli J. PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION? Journal Of Urology 2016, 195: e57-e58. DOI: 10.1016/j.juro.2016.02.2093.
- MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUMBrito J, Rotker K, Lepe M, Quddus M, Manna P, Epstein J, Matoso A, Renzulli J. MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUM. Journal Of Urology 2016, 195: e496. DOI: 10.1016/j.juro.2016.02.1652.
- MP08-05 REDUCED LENGTH OF STAY AND READMISSION RATES USING A STANDARDIZED CLINICAL CARE PATHWAY FOLLOWING ROBOTIC PROSTATECTOMYTurini G, Clark M, Tucci C, Machan J, Golijanin D, Pareek G, Renzulli J. MP08-05 REDUCED LENGTH OF STAY AND READMISSION RATES USING A STANDARDIZED CLINICAL CARE PATHWAY FOLLOWING ROBOTIC PROSTATECTOMY. Journal Of Urology 2016, 195: e86. DOI: 10.1016/j.juro.2016.02.2250.
- PD09-07 THE ROLE OF PATIENT RACE AND ETHNICITY IN PREDICTING PHYSICIAN RECOMMENDATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTINGTurini G, Gjelsvik A, Golijanin D, Pareek G, Renzulli J. PD09-07 THE ROLE OF PATIENT RACE AND ETHNICITY IN PREDICTING PHYSICIAN RECOMMENDATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING. Journal Of Urology 2016, 195: e236. DOI: 10.1016/j.juro.2016.02.2902.
- Communication on the Impact of Multidisciplinary Care in a Large Volume Robot-Assisted Radical Prostatectomy Program: A Paradoxical Stage Migration toward More Aggressive DiseaseLeone A, Diorio G, Mega A, Renzulli J. Communication on the Impact of Multidisciplinary Care in a Large Volume Robot-Assisted Radical Prostatectomy Program: A Paradoxical Stage Migration toward More Aggressive Disease. Journal Of Medical & Surgical Pathology 2016, 1: 1-2. DOI: 10.4172/2472-4971.1000123.
- Reversal of castrate resistant prostate cancer by extracellular vesicle therapy.Mega A, Renzulli J, Quesenberry P, Chatterjee D. Reversal of castrate resistant prostate cancer by extracellular vesicle therapy. Journal Of Clinical Oncology 2015, 33: e16111-e16111. DOI: 10.1200/jco.2015.33.15_suppl.e16111.
- MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN)Leone A, Turini G, Brito J, Tran T, Renzulli J, Pareek G, Golijanin D. MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN). Journal Of Urology 2015, 193: e695-e696. DOI: 10.1016/j.juro.2015.02.2004.
- MP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI-INSTITUTIONAL REVIEWLeone A, Gershman B, Rotker K, Butler C, Fantasia J, Afiadata A, Li J, Sebo T, Zhou A, Jiang Z, Amin A, Mega A, Schiff S, Pareek G, Golijanin D, Yates J, Karnes R, Renzulli J. MP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI-INSTITUTIONAL REVIEW. Journal Of Urology 2015, 193: e157. DOI: 10.1016/j.juro.2015.02.879.
- MP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORSVigneswaran H, Hwang K, Renzulli J, Chan P. MP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORS. Journal Of Urology 2015, 193: e288-e289. DOI: 10.1016/j.juro.2015.02.1213.
- Abstract 2497: Extracellular vesicle-mediated reversal of the prostate cancer phenotypePanagopoulos K, Cross-Knorr S, Renzulli J, Quesenberry P, Chatterjee D. Abstract 2497: Extracellular vesicle-mediated reversal of the prostate cancer phenotype. 2014, 2497-2497. DOI: 10.1158/1538-7445.am2014-2497.
- Is immediate repeat biopsy necessary for men with atypical small acinar proliferation?Butler C, Rotker K, Leone A, Amin A, Schiff S, Pareek G, Golijanin D, Renzulli J. Is immediate repeat biopsy necessary for men with atypical small acinar proliferation? Journal Of Clinical Oncology 2014, 32: e16049-e16049. DOI: 10.1200/jco.2014.32.15_suppl.e16049.
- Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer.Nadeem O, Mega A, Keller E, Renzulli J, Quesenberry P, Chatterjee D. Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer. Journal Of Clinical Oncology 2014, 32: e16028-e16028. DOI: 10.1200/jco.2014.32.15_suppl.e16028.
- MP16-13 RECTAL SWAB CULTURE-DIRECTED ANTIMICROBIAL PROPHYLAXIS FOR PROSTATE BIOPSY IS ASSOCIATED WITH A LOWER RISK OF INFECTIOUS COMPLICATIONSDai J, Hwang K, Mermel L, Pareek G, Schiff S, Golijanin D, Renzulli J. MP16-13 RECTAL SWAB CULTURE-DIRECTED ANTIMICROBIAL PROPHYLAXIS FOR PROSTATE BIOPSY IS ASSOCIATED WITH A LOWER RISK OF INFECTIOUS COMPLICATIONS. Journal Of Urology 2014, 191: e158. DOI: 10.1016/j.juro.2014.02.586.
- MP54-10 MEDIAL PERINEPHRIC FAT, POSTERIOR ABDOMINAL, AND LATERAL ABDOMINAL WALL FAT ARE CORRELATED WITH COMPLICATIONS IN ROBOTIC ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMIES (RALPN)Leone A, Loverme W, Tran T, Elsamra S, Dupuy D, Renzulli J, Pareek G, Golijanin D. MP54-10 MEDIAL PERINEPHRIC FAT, POSTERIOR ABDOMINAL, AND LATERAL ABDOMINAL WALL FAT ARE CORRELATED WITH COMPLICATIONS IN ROBOTIC ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMIES (RALPN). Journal Of Urology 2014, 191: e575-e576. DOI: 10.1016/j.juro.2014.02.1599.
- 766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIALMaddox M, Layton J, Taber A, Mega A, Renzulli J. 766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL. Journal Of Urology 2013, 189: e314-e315. DOI: 10.1016/j.juro.2013.02.330.
- 1213 CONTEMPORARY ANALYSIS OF POST-PROSTATECTOMY SPECIMENS IN A LARGE VOLUME ROBOTIC PROSTATECTOMY PROGRAM: A PARADOXICAL STAGE MIGRATION TOWARD MORE AGGRESSIVE DISEASEMaddox M, Pareek G, Thavaseelan S, Mega A, Renzulli J. 1213 CONTEMPORARY ANALYSIS OF POST-PROSTATECTOMY SPECIMENS IN A LARGE VOLUME ROBOTIC PROSTATECTOMY PROGRAM: A PARADOXICAL STAGE MIGRATION TOWARD MORE AGGRESSIVE DISEASE. Journal Of Urology 2013, 189: e497. DOI: 10.1016/j.juro.2013.02.2567.
- 1248 PROSTATE MRI TO EVALUATE EXTRA-CAPSULAR EXTENSION AND SEMINAL VESICLE INVASION IN PROSTATE CANCER IN A COMMUNITY SETTINGBishop K, Layton J, Furman M, Maddox M, Grand D, Renzulli J, Mega A. 1248 PROSTATE MRI TO EVALUATE EXTRA-CAPSULAR EXTENSION AND SEMINAL VESICLE INVASION IN PROSTATE CANCER IN A COMMUNITY SETTING. Journal Of Urology 2013, 189: e510-e511. DOI: 10.1016/j.juro.2013.02.2602.
- 1943 PROSTATE SPECIFIC ANTIGEN DENSITY VELOCITY ON DUTASTERIDE HELPS PREDICT NEGATIVE PROSTATE BIOPSY: ANALYSIS OF THE REDUCE TRIALMaddox M, Renzulli J, Golijanin D, Elsamra S, Somerville M, Cohen S. 1943 PROSTATE SPECIFIC ANTIGEN DENSITY VELOCITY ON DUTASTERIDE HELPS PREDICT NEGATIVE PROSTATE BIOPSY: ANALYSIS OF THE REDUCE TRIAL. Journal Of Urology 2013, 189: e796-e797. DOI: 10.1016/j.juro.2013.02.2362.
- 801 REVERSAL OF CHEMOSENSITIVITY AND INDUCTION OF CELL MALIGNANCY OF A NON-MALIGNANT PROSTATE CANCER CELL LINE UPON MICROVESICLE EXPOSURECross-Knorr S, Renzulli J, Pantazatos D, Panagopoulos K, Del Tatto M, Goldstein L, Quesenberry P, Chatterjee D. 801 REVERSAL OF CHEMOSENSITIVITY AND INDUCTION OF CELL MALIGNANCY OF A NON-MALIGNANT PROSTATE CANCER CELL LINE UPON MICROVESICLE EXPOSURE. Journal Of Urology 2013, 189: e330. DOI: 10.1016/j.juro.2013.02.365.
- The impact of neoadjuvant weekly ixabepilone for high-risk prostate cancer: A phase I/II clinical trial.Layton J, Plette A, Renzulli J, Miller E, Safran H, Mega A. The impact of neoadjuvant weekly ixabepilone for high-risk prostate cancer: A phase I/II clinical trial. Journal Of Clinical Oncology 2012, 30: 158-158. DOI: 10.1200/jco.2012.30.5_suppl.158.
- Microvesicular-mediated gene transfer of prostate tumor markersRenzulli J, Dooner G, Owens C, Colvin G, Dooner M, Del Tatto M, Goldstein L, Quesenberry P. Microvesicular-mediated gene transfer of prostate tumor markers. Journal Of Clinical Oncology 2009, 27: e16076-e16076. DOI: 10.1200/jco.2009.27.15_suppl.e16076.
- MICROVESICULAR-MEDIATED GENE TRANSFER OF PROSTATE TUMOR MARKERSRenzulli J, Dooner G, Owens C, Colvin G, Quesenberry P. MICROVESICULAR-MEDIATED GENE TRANSFER OF PROSTATE TUMOR MARKERS. Journal Of Urology 2009, 181: 187. DOI: 10.1016/s0022-5347(09)60538-3.
- A BLINDED PROSPECTIVE REPORT OF COMPLICATIONS ASSOCIATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMYLasser M, Renzulli J, Turini G, Haleblian G, Sax H, Pareek G. A BLINDED PROSPECTIVE REPORT OF COMPLICATIONS ASSOCIATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. Journal Of Urology 2009, 181: 578. DOI: 10.1016/s0022-5347(09)61629-3.
- CONVERTING FROM OPEN TO ROBOTIC PROSTATECTOMY: INSTITUTIONAL IMPACT ON NUMBER OF PELVIC LYMPH NODES RETRIEVED DURING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALRP)Yates J, Renzulli J, Iannotti H, Haleblian G, Pareek G. CONVERTING FROM OPEN TO ROBOTIC PROSTATECTOMY: INSTITUTIONAL IMPACT ON NUMBER OF PELVIC LYMPH NODES RETRIEVED DURING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALRP). Journal Of Urology 2008, 179: 50. DOI: 10.1016/s0022-5347(08)60150-0.
- Insulin resistance and glucose transporter expression during the euglycemic hyperinsulinemic clamp in the lambGelardi N, Rapoza R, Renzulli J, Cowett R. Insulin resistance and glucose transporter expression during the euglycemic hyperinsulinemic clamp in the lamb. American Journal Of Physiology 1999, 277: e1142-e1149. PMID: 10600805, DOI: 10.1152/ajpendo.1999.277.6.e1142.